Contents
The KANNO blood group system
Ohto, H., Uchikawa, M., Ito, S., Wada, I., Nollet, K.E., Omae, Y., Ogasawara, K., Tokunaga, K.
Volume 38 (2022): Issue 4 (December 2022)
Use of eVAR and anti-eVAR as interim terms
Nance, Sandra
To contributors to the 2022 issues
Keller, Margaret A., Flickinger, Cynthia
Rare case of clinically significant anti-c in a 1-year-old pediatric patient
Malhotra, Sheetal, Jain, Ashish, Sharma, Ratti Ram, Peyam, Srinivasan
RHCE variant alleles and risk of alloimmunization in Brazilians
Arnoni, C.P., Vendrame, T.A.P., Silva, F.S., Cortez, A.J.P., Latini, F.R.M., Castilho, L.
Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system
Ilsley, M.D., Storry, J.R., Olsson, M.L.
Post COVID-19 vaccination and adverse events: correspondence
Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Investigating anti-D in an individual with the weak D type 2 genotype
Phou, S., Nguyen, N., Revilla, J., Rodberg, K., Gibb, D.R., Pepkowitz, S.H., Klapper, E.B.
Enzyme treatment of red blood cells: use of ficin and papain
Bruce, B.
Procuring rare (珍しい)* Japanese red blood cell units for a bleeding patient with anti-K11 requiring a life-saving procedure
Rodriguez, J.V., Tormey, C.A.